Dr. Constancio Medrano López

Spécialiste en cardiologie pédiatrique et fœtale à l'Hôpital Quirónsalud de Tolède.
  • Pediatric Cardiology
Dr. Constancio Medrano López

Centros de los Médicos Dr. Constancio Medrano López

Internacional 2019: Centros a los que pertenezca un médico.

Expérience professionnelle
  • Head of Pediatric Cardiology Section and Coordinator of the Children's Heart Area. Gregorio Marañón General University Hospital, Madrid.
  • Specialist in Pediatric Cardiology at Quirónsalud La Luz, Sur and Toledo Hospitals.
  • Assistant Doctor of Pediatric Cardiology and Head of the Non-Invasive Cardiology Unit at the Hospital General Universitario Gregorio Marañón in Madrid. From 2006 to 2013
  • Assistant Doctor of Pediatric Cardiology in the Children's Heart Area of the University Hospital Complex of A Coruña. From 1997 to 2006.
  • Pediatric Adjunct Medical Specialist. Santa Barbara Hospital. Puertollano (Ciudad Real). January to May 1997.
Appartenance à des sociétés scientifiques

President of the Spanish Society of Pediatric Cardiology and Congenital Heart Disease.

Recherche et enseignement
  • Associate Professor of Pediatrics. Faculty of Medicine. Complutense University of Madrid
  • Member of the Research Commission and Head of Training at the Gregorio Marañon Health Research Institute in Madrid. From 2008 to the present.
  • Principal Investigator in R+D+i projects financed in public competitive calls:

    Stem Cell Therapy: Feasibility and safety clinical trial of intramyocardial injection of autologous bone marrow-derived stem cells in children with hypoplastic left ventricular syndrome. The TABHY study. Carlos III Institute of Health

    Drugs in Pulmonary Hypertension: Sildenafil in postoperative cardiac surgery in children. IVORY study. Carlos III Health Institute.

    Familial Cardiopathies and Genetics: MYESTELA Study: Multicentric Study of Myocardiopathies in Childhood. Genetic study and with new echocardiographic techniques (2D Speckle tracking) and familial impact. Carlos III Health Institute.
  • Coordinator-Principal Investigator in privately funded R+D+I projects:

    National Coordinator of the CIVIC Studies (Epidemiological studies of acute respiratory infections due to respiratory syncytial virus in children with heart disease). Spanish Society of Pediatric Cardiology and Congenital Heart Disease (SECPCC) - Abbvie. From 2004 to the present.

    Regional Coordinator (Europe II) and Member of the Steering Committee of the CLARINET Study: International, multicenter clinical trial on the use of clopidogrel in young children to reduce the risk of thrombosis in ducts and systemic pulmonary fistulas in cyanogenic congenital heart disease. Start in 2006
Séjour dans des centres étrangers

Visiting Medical Specialist in the Pediatric Cardiology Service (Hemodynamics and Fetal Cardiology) at the Hospital Sainte Justine de Montréal (Québec, Canada). 1999.

Langues pour la pratique clinique